|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
30.620 -1.140 (-3.589%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 77,857 | (168,787) | (916,252) | (1,887,599) |
| Net Cash from / (used in) Investing Activities | -- | 364,804 | 3,962 | (441,622) | (1,191,955) |
| Net Cash from / (used in) Financing Activities | -- | (766,216) | (334,184) | (7,582) | 854,602 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (323,555) | (499,009) | (1,365,456) | (2,224,952) |
| Cash & Cash Equivalents at beginning of period | -- | 1,555,805 | 2,046,099 | 3,391,268 | 5,455,456 |
| Effect of Foreign Exchange Rate Changes | -- | (12,981) | 8,715 | 20,287 | 160,764 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,219,269 | 1,555,805 | 2,046,099 | 3,391,268 |
| Remarks: | Real time quote last updated: 31/08/2026 09:21 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -721 |
| %Change | -94.653% |
| EPS / (LPS) | RMB -0.003 |
| NBV Per Share (¥) | RMB 20.150 |